Patent foramen ovale (PFO) is a normal fetal communication between the right and left atria
that persists after birth. PFO is a common finding that occurs in 20–34% of the population …

Background and Purpose—Patients discovered to have a patent foramen ovale in the
setting of a cryptogenic stroke may be treated with percutaneous closure, antiplatelet …

OBJECTIVE: Amplatzer (AGA Medical Corporation, Plymouth, Minn) septal and vascular
occluder devices have significantly altered the care of patients with congenital heart …

We have conducted a systematic review of air embolism complications of neurosurgery in
the sitting position and patent foramen ovale (PFO) closure. It assesses the risk and benefit …

Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …

Abstract “Smart Materials” are materials that change their shape, color, or size in response to
an externally applied stimulus. While smart materials have already made a tremendous …

Objective. To summarize major complications and outcome for patients receiving
percutaneous closure of atrial septal communications. Design. The Medline database and …

Objectives: The purpose of this study was to evaluate the efficacy and safety of device
closure of patent foramen ovale (PFO) versus antiplatelet therapy in patients with …

Patent foramen ovale (PFO) has been linked to ischemic strokes of undetermined cause
(cryptogenic strokes). PFO—a remnant of fetal circulation when the foramen ovale does not …